[1]
H. Dabar and S. Guniganti, “Evaluating The Fraud Triangle Perspective in India’s Pharmaceutical Sector”, IJAES, vol. 12, no. 8, pp. 445–455, Dec. 2025, doi: 10.14419/eb2vzn51.